|Bid||58.49 x 1800|
|Ask||58.50 x 1000|
|Day's Range||58.48 - 58.54|
|52 Week Range||13.15 - 60.69|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 03, 2021 - May 07, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.64|
Cara Therapeutics Inc. (NASD:CARA) will replace MTS Systems Corp. (NASD:MTSC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 8. S&P 500 constituent Amphenol Corp. (NYSE: APH) is acquiring MTS Systems in a deal expected to be completed soon pending final closing conditions.
MTS Systems Corporation (Nasdaq: MTSC) ("MTS") today announced that, based on the preliminary voting results from a special meeting of shareholders held today, MTS' shareholders have approved the adoption of the previously announced merger agreement relating to the proposed transaction between MTS and Amphenol Corporation (NYSE: APH) ("Amphenol"), whereby MTS will become a wholly-owned subsidiary of Amphenol (the "Merger").
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: